Article
A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid.
Journal of medical genetics - 1 Sept 1997
Smith C A, Wadelius M, Gough A C, Harrison D J, Wolf C R, Rane A
Abstract excerpt
Human arylamine N-acetyltransferase (NAT) activity is determined by two distinct genes, NAT1 and NAT2, and the classical acetylation polymorphism in NAT2 has been associated with a variety of disorders, including lupus erythematosus and arylamine induced cancers. Over 50% of the white population exhibit a slow acetylator phenotype. The genetic basis of the defect has been identified and several DNA based assays...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
